Insitro

Sign in
Organization banner, image 1 of 3
Organization banner, image 2 of 3
Organization banner, image 3 of 3

Open roles

  • Insitro logo
    Lead/ Senior Machine Learning Scientist, Integrative Phenotyping

    Insitro

    • South San Francisco, CA
    • Hybrid · Senior
    • $183k–$224k
    AI-native
    Ashby
    Posted 9d ago
  • Insitro logo
    Vice President, FP&A & Financial Transformation

    Insitro

    • South San Francisco, CA
    • Hybrid · Director / Executive
    • $300k–$345k
    AI-native
    Ashby
    Posted 21d ago
  • Insitro logo
    Vice President, Regulatory Affairs

    Insitro

    • South San Francisco, CA
    • Hybrid · Director / Executive
    • $313k–$333k
    Ashby
    Posted 22d ago
  • Insitro logo
    Director, Financial Reporting & Technical Accounting

    Insitro

    • South San Francisco, CA
    • Hybrid · Director / Executive
    • $217k–$231k
    AI-native
    Ashby
    Posted 28d ago
  • Insitro logo
    Full Stack Software Engineer, Lab Platform (LIMS)

    Insitro

    • South San Francisco, CA
    • Hybrid · Mid-level
    • $111k–$140k
    AI-native
    Ashby
    Posted 50d ago
  • Insitro logo
    Senior Manager / Director, Statistical Genetics

    Insitro

    • South San Francisco, CA
    • Hybrid · Director / Executive
    • $224k–$273k
    AI-native
    Ashby
    Posted 54d ago
Show all roles

About

Insitro logo

Insitro

insitro is the physical AI company built on causal biology.

insitro is the physical AI company unlocking causal human biology, founded and led by AI pioneer Daphne Koller. By generating the world’s largest integrated multi-modal corpus of human and cellular data, we’ve built the Virtual Human™ – a genetically anchored causal AI engine that reveals how disease begins, progresses, and can be resolved. Our platform enables us to precisely identify causal genetic drivers and deploy our TherML™ AI platform to design optimal medicines, advancing a broad pipeline of therapeutics for neuroscience and metabolic diseases. This industrialized architecture creates a self-learning loop: with every biology we onboard, our predictive models grow smarter, accelerating discovery across scales of biology. Join us in transforming the future of medicine!

Private companySeries CIn the news
Founded2018
HQSan Francisco, United States
Size
258 employees
IndustryBiotechnology Research
Latest fundingSeries C · Mar 15, 2021
Investors
CPP Investments
News
  • The AI Moment in Drug Discovery: Daphne Koller on The Long Run

Claim insitro.com

Work at insitro.com? Sign in to claim this org and manage its profile.

ThesisExploreTermsPrivacy
© 2026 Saywise Inc.